[{"Assets_0_Q3_USD":64305000000.0,"CommonStockSharesOutstanding_0_Q3_shares":1294000000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":6055000000.0,"NetIncomeLoss_1_Q3_USD":2097000000.0,"NetIncomeLoss_3_Q3_USD":5452000000.0,"Dividends_3_Q3_USD":2245000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":1307000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":1313000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":1296000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":1302000000.0,"StockholdersEquity_0_Q3_USD":22861000000.0,"EarningsPerShareBasic_1_Q3_USD":1.62,"EarningsPerShareBasic_3_Q3_USD":4.19,"EarningsPerShareDiluted_1_Q3_USD":1.6,"EarningsPerShareDiluted_3_Q3_USD":4.15,"Ticker":"GILD","CIK":"882095","name":"GILEAD SCIENCES INC","OfficialName":"Gilead Sciences Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"78838305412.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20181106"}]